ResearcherKeio UniversityNo recent work listed
Takahiro Yokose
Matched on ORCID iD 0000-0001-6946-280X; OpenAlex author ID A5079301585. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2020: 3 papers
Papers 3
- Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant thera… Co-author DOI 10.1002/cam4.3044↗
- Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer. Co-author DOI 10.1111/cas.14425↗
- O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. Co-author DOI 10.3390/cancers12092469↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shutaro Hori · 3 shared papers, 2020 · strength 0.25
- Paper Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cance… DOI 10.1111/cas.14425↗
- Paper Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and… DOI 10.1002/cam4.3044↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Minoru Kitago · 3 shared papers, 2020 · strength 0.25
- Paper Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cance… DOI 10.1111/cas.14425↗
- Paper Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and… DOI 10.1002/cam4.3044↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Yuta Abe · 3 shared papers, 2020 · strength 0.25
- Paper Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cance… DOI 10.1111/cas.14425↗
- Paper Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and… DOI 10.1002/cam4.3044↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Yohei Masugi · 3 shared papers, 2020 · strength 0.25
- Paper Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cance… DOI 10.1111/cas.14425↗
- Paper Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and… DOI 10.1002/cam4.3044↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Yuko Kitagawa · 3 shared papers, 2020 · strength 0.25
- Paper Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cance… DOI 10.1111/cas.14425↗
- Paper Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and… DOI 10.1002/cam4.3044↗
- Paper O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. DOI 10.3390/cancers12092469↗
- Yutaka Endo · 2 shared papers, 2020 · strength 0.18
- Yutaka Nakano · 2 shared papers, 2020 · strength 0.17
- Takashi Tokino · 1 shared paper, 2020 · strength 0.09
- Kodai Abe · 1 shared paper, 2020 · strength 0.09
- Masahiro Jinzaki · 1 shared paper, 2020 · strength 0.09
- Ayumi Kashiro · 1 shared paper, 2020 · strength 0.07
- Atsushi Matsuda · 1 shared paper, 2020 · strength 0.07
- Satoshi Nara · 1 shared paper, 2020 · strength 0.07
- Atsushi Kuno · 1 shared paper, 2020 · strength 0.07
- Michiie Sakamoto · 1 shared paper, 2020 · strength 0.07
- Yasuaki Kabe · 1 shared paper, 2020 · strength 0.07
- Kazufumi Honda · 1 shared paper, 2020 · strength 0.07
- Chigusa Morizane · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.